EpiThany

EpiThany is committed to advancing innovative therapies to improve the lives of cancer patients. EpiThany's focus is on developing tumor vaccines that can drive Th1 (tumor-eradicating) immune responses without stimulating competitive Th2 (tumor-tolerant) reactions.